[Influence of long-term therapy with enalapril on late postinfarction remodeling and functional state of the left ventricle in patients with diastolic heart failure.].
Enalapril (average dose 7,0+/-0.8 mg) was given for 12 weeks to 15 patients with preserved left ventricular (LV) systolic function who had survived large focal myocardial infarction small i, Ukrainian6 months before that. The use of enalapril was associated with 49% lessening of severity of clinical signs of heart failure (p<0.001) and 47% increase of tolerance to physical exercise. It also provided dose dependent 17.8% reduction of LV myocardial mass (p<0.05), normalization of initially "hypertrophic" type of transmitral flow, 21% lowering of LV end diastolic pressure (p<0.05) without effect on LV volume, geometry, global and local systolic function.
Research Institute for Cardiology of the Research Centre of RAMS Siberian Branch; ul. Kievskaya, 111, 634012 Tomsk, Russia.
V V
VV
Kaliuzhin
M A
MA
Solovtsov
A T
AT
Tepliakov
E V
EV
Kaliuzhina
M A
MA
Maleeva
E Iu
EIu
Pushnikova
D Iu
DIu
Kamaev
D004656:Enalapril; D006333:Heart Failure; D054144:Heart Failure, Diastolic; D006352:Heart Ventricles; D006801:Humans; D016277:Ventricular Function, Left
D004656:Enalapril